ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

NCT01336088 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: ADX48621
DRUG: Placebo

Sponsor

Addex Pharma S.A.